A screen of candidates from peaks of linkage: Evidence for the involvement of myeloperoxidase in multiple sclerosis

Journal of Neuroimmunology

Volumn 98, Issue 2, 1999, Pages 208-213

  Chataway, Jeremy ^a   Sawcer, Stephen ^a   Feakes, Robert ^a   Coraddu, Francesca ^a   Broadley, Simon ^a   Jones, Hywel B ^b   Clayton, David ^b   Gray, Julia ^a   Goodfellow, Peter N ^a   Compston, Alastair ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c Forvie Site   (United Kingdom)

Author keywords

Genome screen; Multiple sclerosis; Myeloperoxidase gene

Indexed keywords

MYELOPEROXIDASE;

ADULT; ARTICLE; FEMALE; GENE; GENETIC LINKAGE; GENETIC MARKER; GENOME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SCREENING;

ADULT; ALLELES; DISEASE SUSCEPTIBILITY; DNA PRIMERS; DNA, SATELLITE; FEMALE; GENETIC MARKERS; GENETIC SCREENING; HUMANS; LINKAGE (GENETICS); MALE; MULTIPLE SCLEROSIS; PEROXIDASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0033046020     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00089-2     Document Type: Article

References (26)

1. Barcellos L.F., Thomson G., Carrington M., Schafer J., Begovich A.B., Lin P., Xu X.H., Min B.Q., Marti D., Klitz W. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese. J. Am. Med. Assoc. 278:1997;1256-1261.
2. Cuzner M.L., Gveric D., Strand C., Loughlin A.J., Paemen L., Opdenakker G., Newcombe J. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55:1996;1194-1204.
3. Dyment D.A., Sadovnick A.D., Ebers G.C. Genetics of multiple sclerosis. Hum. Mol. Genet. 6:1997;1693-1698.
4. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R.B., Hader W., Paty D.W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J.E., Murray T.J., Pryse-Phillips W., Nelson R., Freedman M., Brunet D., Bouchard J.P., Hinds D., Risch N. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
5. Edelmann W., Zervas M., Costello P., L R., Fischer I., Hammarback J.A., Cowan N., Davies P., Wainer B., Kucherlapati R. Neuronal abnormalities in microtubule-associated protein 1B mutant mice. Proc. Natl. Acad. Sci. USA. 93:1996;1270-1275.
6. Ferner R.E., Hughes R.A.C., Johnson M.R. Neurofibromatosis 1 and multiple sclerosis. J. Neurol. Neurosurg. Psych. 58:1995;582-585.
7. Goetzl E.J., Banda M.J., Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 156:1996;1-4.
8. Haines J.L., Ter-Minassian M., Bazyk A., Gusella J.F., Kim D.J., Terwedow H., Pericak-Vance M.A., Rimmler J.B., Haynes C.S., Roses A.D., Lee A., Shaner B., Menold M., Seboun E., Fitoussi R.P., Gartioux C., Reyes C., Ribierre F., Gyapay G., Weissenbach J., Hauser S.L., Goodkin D.E., Lincoln R., Usuku K., Garcia-Merino A., Gatto N., Young S., Oksenberg J.R. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
9. Hogancamp W.E., Rodriguez M., Weinshenker B.G. The epidemiology of multiple sclerosis. Mayo Clin. Proc. 72:1997;871-878.
10. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikstrom J., Palo J., Stein L.D., Hudson T.J., Lander E.S., Peltonen L. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61:1997;1379-1387.
11. Maeda A., Sobel R.A. Matrix metalloproteinases in the normal human central nervous system. J. Neuropathol. Exp. Neurol. 55:1996;300-309.
12. Moller J.R., Yanagisawa K., Brady R.O., Tourtellote W.W., Quarles R.H. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis. Ann. Neurol. 22:1987;469-474.
13. Nagra R.M., Becher B., Tourtellote W.W., Antel J.P., Gold D., Paladino T., Smith R.A., Nelson J.R., Reynolds W.F. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78:1997;97-107.
14. Ott, J., 1991. Analysis of Human Genetic Linkage. The John Hopkins University Press, Baltimore.
15. Pericak-Vance M.A., Seboun E., Goodkin D.E., Rimmler J., Lincoln R., Oksenberg J., Yamaoka L., Roses A.D., Gusella J.F., Haines J.L. Segregation with markers on chromosome 19q suggest a susceptibility locus for multiple sclerosis (MS). Am. J. Hum. Genet. 55(S1158):1994;A199.
16. Poser C.M., Paty D.W., Scheinberg L., McDonald I.w., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
17. Reed P.W., Davies J.L., Copeman J.B., Bennett S.T., Palmer S.M., Pritchard L.E., Gough S.C.L., Kawaguchi Y., Cordell H.J., Balfour K.M., Jenkins S.C., Powell E.E., Vignal A., Todd J.A. Chromosome-specific microsatellite sets for fluorescence-based, semiautomated genome mapping. Nat. Genet. 7:1994;390-395.
18. Reynolds W.F., Chang E., Douer D., Ball E.D., Kanda V. An allelic association implicates myeloperoxidase in the aetiology of acute promyelocytic leukaemia. Blood. 90:1997;2730-2737.
19. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
20. Robertson N.P., Fraser M., Deans J., Clayton D., Walker N., Compston D.A.S. Age adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain. 119:1996;449-455.
21. Sadovnick A.D., Baird P.A., Ward R.H. Multiple sclerosis: updated risks for relatives. Am. J. Med. Genet. 29:1988;533-541.
22. Sawcer S.J., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosomes 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
23. Sawcer S.J., Goodfellow P.N., Compston D.A.S. The genetic analysis of multiple sclerosis. TIGs. 13:1997;234-239.
24. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59:1996;983-989.
25. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
26. Walsh M.J., Murray J.M. Dual implication of 2′,3′-cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J. Clin. Invest. 101:1998;1923-1931.